1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Reviews

Discussion in 'SkinMedica' started by Anonymous, Feb 27, 2014 at 12:20 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Anyone actually happy with their review????
     

  2. Anonymous

    Anonymous Guest

    No, I'm on a plan. I thought that 2013 was a wash. Thanks SKM! Guess I better start looking for a job. Hate this company anyway. I thought that I would stick it out and hope for changes to be positive for 2014. Definitely will never get better unless the corporate want to be leaders get fired too. Allergan please axe the senior leadership team in Carlsbad.
     
  3. Anonymous

    Anonymous Guest

    I wonder how many people are on a plan! Probably a lot! My SAM and manager should be on one!
     
  4. Anonymous

    Anonymous Guest

    Mine should be too! This is not fair the RSM's have no accountability in any of this! Fire them too you morons!! Or you sleeping with them too!!
     
  5. Anonymous

    Anonymous Guest

    Mine was horrible! Worst of my life. Zero perspective from mgt. my numbers were good but review sucked! Ugh!
     
  6. Anonymous

    Anonymous Guest

    Good